Saturday 17 October 2026 Export STLN’s income statement to Excel — free account

Starling Oncology, Inc.

Starling Oncology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $502.7 million, up 27.8% from fiscal 2024. In the quarter to June 2026, revenue grew 34.6%, EPS grew 46.7%, free cash flow grew 196.7% and total debt rose 6.46%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

6.43 0.48 −6.95%

Follow STLN

Alert me

Market cap: $690.9M
P/E: 0.0×
Fwd P/E: −32.5×
Dividend yield: —
F-score: 4/9
Altman Z: 1.42
Beneish M: −3.39
Dividend safety: n/a

Overview Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	0.00	0.00	0.00	0.00
P/S ratio Full definition →		0.74	0.65	0.57	0.95
P/FCF ratio Full definition →		0.00	0.00	0.00	0.00
P/Operating CF Full definition →		(26.93)	101.73	(141.10)	46.86
P/B ratio Full definition →		0.00	0.00	0.00	0.00
Price to Tangible BV Full definition →		0.00	0.00	0.00	0.00
EV/Sales Full definition →		0.84	0.74	0.66	1.02
EV/EBITDA Full definition →		0.00	0.00	0.00	0.00
EV/Operating CF Full definition →		(16.46)	(15.17)	(16.55)	1,824.43
EV/FCF Full definition →		(14.13)	(13.42)	(14.03)	(182.11)
Quick Ratio Full definition →		1.34	1.31	1.13	1.14
Current Ratio Full definition →		1.68	1.59	1.47	1.36
Net Debt/EBITDA Full definition →		(9.41)	(10.77)	(13.11)	(25.47)
Debt/Assets Full definition →		46.57%	47.01%	46.73%	44.81%
Debt/Equity Full definition →		(6.21)	(4.92)	(4.83)	(3.21)
Asset Turnover Full definition →		2.69	2.98	3.29	3.47
Operating CF/Net income Full definition →		0.77	(0.43)	0.89	(1.22)
Capex/Depreciation Full definition →		(0.21)	(0.37)	(0.37)	(0.29)
Interest Coverage Full definition →		(4.19)	(3.60)	(3.37)	(2.48)
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		18.49%	19.75%	19.13%	18.57%
Intangible Assets out of Total Assets Full definition →		0.12	0.11	0.10	0.09
Share Based Compensation of Revenue Full definition →		0.75%	0.93%	1.14%	0.66%
Graham Net Nets Full definition →		(0.19)	(0.21)	(0.22)	(0.13)
Graham Number Full definition →		1.35	1.46	1.15	1.28
Earnings Yield Full definition →		(18.34%)	(15.73%)	(12.05%)	(5.52%)
Free Cash Flow Yield Full definition →		(8.09%)	(8.45%)	(8.23%)	(0.59%)
Revenue per Share Full definition →		1.40	1.54	1.45	1.57
Operating CF per Share Full definition →		(0.13)	0.04	(0.02)	0.12
Capex per Share Full definition →		(0.01)	(0.01)	(0.01)	(0.01)
Free Cash Flow per Share Full definition →		(0.14)	0.02	(0.03)	0.11
Cash per Share Full definition →		0.28	0.36	0.30	0.40
Shareholders Equity per Share Full definition →		(0.13)	(0.17)	(0.16)	(0.24)
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		(0.13)	(0.17)	(0.16)	(0.24)
Free Cash Flow Full definition →		(13.23)	2.17	(3.26)	11.03
Working Capital Full definition →		44.51	41.79	37.51	34.05
Capital Expenditures Full definition →		(0.60)	(1.06)	(1.04)	(0.91)
Net Current Asset Value Full definition →		(65.80)	(67.63)	(67.65)	(74.16)
EV/EBIT Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.00	0.01	0.01	0.01
Price to Operating Income Full definition →		0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →		57.42	54.00	54.56	61.32
Average Payables Full definition →		30.10	33.75	38.47	47.61
Average Inventory Full definition →		14.49	13.46	18.30	17.90
Average Assets Full definition →		171.40	168.69	166.12	169.02
Average Common Equity Full definition →		1.60	(6.07)	(5.61)	(16.95)

Fold the line items

Columns are period end dates

Stockrow Weekly